Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation

Hum Gene Ther. 1996 Mar 20;7(5):655-67. doi: 10.1089/hum.1996.7.5-655.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antigens, CD34
  • Bone Marrow / drug effects
  • Bone Marrow / immunology
  • Bone Marrow Cells*
  • Bone Marrow Transplantation*
  • Child
  • Clinical Protocols
  • Cytokines / pharmacology
  • Genetic Markers / genetics*
  • Genetic Vectors*
  • Humans
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Retroviridae / genetics*
  • Transplantation, Autologous

Substances

  • Antigens, CD34
  • Cytokines
  • Genetic Markers